{"gene":"MBD1","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":2001,"finding":"Solution structure of the MBD of human MBD1 bound to methylated DNA was determined by NMR. DNA binding causes a loop in MBD1 to fold into a novel DNA binding interface; recognition of methyl groups and CG sequence is mediated by five highly conserved residues forming a hydrophobic patch (including Asp32, Tyr34, Arg44).","method":"Multi-dimensional heteronuclear NMR spectroscopy with site-directed mutagenesis","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 / Strong — atomic-resolution NMR structure with mutagenesis validation, replicated by earlier unbound MBD structure (PMID:10581239)","pmids":["11371345"],"is_preprint":false},{"year":1999,"finding":"Solution structure of the free MBD of human MBD1 determined by NMR; it folds into an alpha/beta-sandwich with a large positively charged surface identified as the DNA interaction site. Conserved residues Tyr34, Asp32, and three basic residues are critical for DNA binding, established by site-directed mutagenesis and chemical shift mapping.","method":"Multi-dimensional heteronuclear NMR spectroscopy with site-directed mutagenesis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — atomic-resolution NMR structure with mutagenesis validation in a focused mechanistic study","pmids":["10581239"],"is_preprint":false},{"year":1999,"finding":"MBD1 possesses isoforms (v1/v2 with CXXC1-3; v3/v4 with CXXC1-2) due to alternative splicing. The CXXC3 domain in isoforms v1/v2 confers binding to unmethylated DNA and transcriptional repression of unmethylated promoters, whereas the MBD confers methylation-dependent repression. Both the MBD and CXXC domains, plus the C-terminal TRD, cooperate for transcriptional regulation.","method":"Transfection of GFP-fused isoforms in methylation-deficient Drosophila SL2 and mammalian CHO-K1 cells; reporter assays; EMSA with bacterially expressed domains","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple isoforms tested with domain mutants, reporter assays, and DNA binding in two cell systems; replicated across multiple papers","pmids":["10454587","10866667"],"is_preprint":false},{"year":2000,"finding":"MBD1 contains a powerful C-terminal transcriptional repression domain (TRD) that actively represses transcription at a distance. Methylation-dependent repression in vivo requires both the TRD and the MBD. Repression is sensitive to trichostatin A (HDAC inhibitor), indicating dependence on histone deacetylation. Endogenous MBD1 concentrates at centromeric heterochromatin where acetylated H4 is deficient. MBD1 is not a component of the MeCP1 complex.","method":"Transient transfection reporter assays; trichostatin A treatment; immunofluorescence localization; co-immunoprecipitation (negative for MeCP1)","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (reporter assays, pharmacological inhibition, localization), replicated in subsequent work","pmids":["10648624"],"is_preprint":false},{"year":2003,"finding":"MBD1 directly interacts with histone H3 methylase Suv39h1 and methyl-lysine binding protein HP1 via its MBD in vitro and in cells. Suv39h1 enhances MBD1-mediated transcriptional repression through the MBD (not the TRD). MBD1 links to HDACs through Suv39h1, resulting in coupled H3K9 methylation and histone deacetylation for gene inactivation.","method":"In vitro GST pulldown; co-immunoprecipitation; reporter gene assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP and in vitro pulldown with functional reporter assays; replicated in subsequent studies","pmids":["12711603"],"is_preprint":false},{"year":2003,"finding":"MBD1 interacts with the p150 subunit of chromatin assembly factor 1 (CAF-1), forming a multiprotein complex that also contains HP1alpha. The interaction requires the MBD of MBD1 and maps to the C-terminus of CAF-1 p150. Overexpression of the CAF-1 p150 C-terminus displaces MBD1 from heterochromatic foci without disrupting global heterochromatin structure.","method":"Co-immunoprecipitation; immunofluorescence colocalization; dominant-negative overexpression","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP with domain mapping, localization studies, and functional dominant-negative experiment; confirmed in PMID:15327775","pmids":["12697822"],"is_preprint":false},{"year":2003,"finding":"A mediator protein MCAF (MBD1-containing chromatin-associated factor) interacts with the TRD of MBD1, identified by yeast two-hybrid. MCAF interacts with both MBD1 and the transcription factor Sp1. The MBD1-MCAF complex blocks transcription through Sp1 on methylated promoters via a histone deacetylation-resistant mechanism.","method":"Yeast two-hybrid; co-immunoprecipitation; reporter gene assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — yeast two-hybrid identification confirmed by Co-IP and reporter assays; expanded in PMID:15691849","pmids":["12665582"],"is_preprint":false},{"year":2004,"finding":"MBD1 forms a stable complex with histone H3K9 methylase SETDB1. During S phase, MBD1 recruits SETDB1 to the CAF-1 p150 subunit to form an S phase-specific CAF-1/MBD1/SETDB1 complex that facilitates H3K9 methylation during replication-coupled chromatin assembly. Absence of MBD1 causes loss of H3K9 methylation at multiple genomic loci and derepression of p53BP2.","method":"Co-immunoprecipitation; ChIP; siRNA knockdown; cell fractionation during S phase","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (Co-IP, ChIP, KD with gene expression readout), replicated by independent studies","pmids":["15327775"],"is_preprint":false},{"year":2004,"finding":"Mouse Mbd1 isoform Mbd1a contains a CXXC3 domain that binds specifically to nonmethylated CpG sites in vivo and in vitro, explaining methylation-independent heterochromatin localization. CXXC3-mediated targeting is responsible for repression of nonmethylated reporter genes, while MBD-mediated binding is required for repression of methylated reporters.","method":"Transfection studies with domain mutants; DNA binding assays; fluorescence microscopy in methylation-deficient mouse cells","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — domain dissection with in vivo targeting and reporter assays; convergent with PMID:10866667","pmids":["15060159"],"is_preprint":false},{"year":2005,"finding":"MCAF1 (ATF7ip/AM) is required for transcriptional repression and heterochromatin formation by MBD1, together with SETDB1. Both MCAF1 and a newly identified MCAF2 interact with MBD1, SETDB1, and Sp1 via two conserved distinct domains. An MBD1 mutant lacking MCAF interaction perturbs HP1-enriched heterochromatin formation, establishing the MBD1·MCAF1·SETDB1 complex as required for heterochromatic domain formation.","method":"Co-immunoprecipitation; in vitro binding; siRNA knockdown; immunofluorescence; reporter assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods including KD rescue and domain-mutant localization studies","pmids":["15691849"],"is_preprint":false},{"year":2005,"finding":"The intracellular domain of teneurin-1 interacts with MBD1 and co-localizes with it in nuclear matrix-associated foci, identified by yeast two-hybrid and validated by co-transfection and co-localization studies.","method":"Yeast two-hybrid; co-transfection; co-localization immunofluorescence; nuclear fractionation","journal":"Experimental cell research","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — yeast two-hybrid confirmed by co-localization but no functional consequence of the interaction established","pmids":["15777793"],"is_preprint":false},{"year":2006,"finding":"MBD1 is SUMOylated at two conserved C-terminal lysine residues by PIAS1 and PIAS3 E3 SUMO ligases. Sumoylated MBD1 can still bind methylated DNA but fails to form a complex with SETDB1 and cannot efficiently repress target gene p53BP2, indicating that SUMO conjugation antagonizes formation of the repressive MBD1-SETDB1 complex.","method":"In vivo sumoylation assay; co-immunoprecipitation; reporter gene assay; site-directed mutagenesis of SUMO acceptor lysines","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — mutagenesis of modification sites combined with Co-IP and functional reporter assay in single study with multiple methods","pmids":["17066076"],"is_preprint":false},{"year":2006,"finding":"SUMOs (SUMO-2/3 and SUMO-1) directly interact with MCAF1. SUMOylation of MBD1 facilitates the interaction between MBD1 and MCAF1. Knockdown of SUMO-2/3 or SUMO-1 causes dissociation of MCAF1, trimethyl-H3K9, and HP1 proteins from MBD1-containing heterochromatin foci, demonstrating that SUMOs are required for heterochromatin assembly at MBD1 loci.","method":"Co-immunoprecipitation; siRNA knockdown; immunofluorescence","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and KD with localization readout, single lab study","pmids":["16757475"],"is_preprint":false},{"year":2006,"finding":"PML-RARalpha recruits MBD1 to its target promoter through an HDAC3-mediated mechanism. Knockdown of HDAC3 alleviates PML-RAR-induced promoter silencing. Dominant-negative MBD1 mutants in hematopoietic precursors compromise PML-RARalpha's ability to block differentiation, demonstrating that an HDAC3-MBD1 complex is required for PML-RARalpha-mediated transcriptional repression and transformation.","method":"ChIP; siRNA knockdown; retroviral expression of dominant-negative MBD1; differentiation assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (ChIP, KD, dominant-negative genetics) with functional cellular readout","pmids":["16432238"],"is_preprint":false},{"year":2007,"finding":"MBD1 interacts with PcG proteins Ring1b and hPc2 (components of Polycomb repressive complex 1) via its CXXC domains (Ring1b) and the chromodomain of hPc2. Both MBD1 and hPc2 are present at silenced HOXA gene loci; knockdown of either derepresses HOXA genes. An MBD1 mutant lacking CXXC domains loses co-localization with PcG proteins in heterochromatin foci.","method":"Co-immunoprecipitation; ChIP; siRNA knockdown; immunofluorescence with domain mutants; 5-azadeoxycytidine treatment","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods including reciprocal Co-IP, ChIP, KD, and domain-mutant localization","pmids":["17428788"],"is_preprint":false},{"year":2008,"finding":"Mbd1 binds to the Fgf-2 promoter in adult neural stem/progenitor cells (NSPCs) and represses its expression via a DNA methylation-dependent mechanism. In Mbd1-deficient NSPCs, the Fgf-2 promoter is hypomethylated and Fgf-2 is upregulated, leading to impaired neuronal differentiation. Acute knockdown of Mbd1 or overexpression of Fgf-2 both inhibit neuronal differentiation.","method":"ChIP; bisulfite sequencing; DNA methylation inhibitor treatment; siRNA knockdown; overexpression in adult NSPCs","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP, bisulfite sequencing, and functional KD/OE with differentiation readout, multiple orthogonal methods","pmids":["18689796"],"is_preprint":false},{"year":2010,"finding":"MBD1 directly represses miR-184 expression in adult neural stem/progenitor cells. MBD1 deficiency leads to elevated miR-184, which promotes proliferation and inhibits differentiation. miR-184 targets the 3'-UTR of Numblike (Numbl) mRNA to suppress its translation. Expression of exogenous Numbl rescues the aNSC defects from miR-184 overexpression or MBD1 deficiency, establishing a MBD1→miR-184→Numbl regulatory axis.","method":"ChIP; luciferase 3'-UTR reporter assay; miRNA overexpression/inhibition; rescue experiments in aNSCs","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP, reporter assays, gain/loss-of-function, and rescue experiments with multiple orthogonal methods","pmids":["20452318"],"is_preprint":false},{"year":2010,"finding":"The MBD domain of MBD1 binds methylated DNA with sequence-context preference and is necessary and sufficient for recruitment of MBD1 to specific genomic loci in human cells. CXXC3 DNA binding is largely dispensable for in vivo targeting to methylated target genes.","method":"ChIP; in vitro DNA binding assays with purified domains; MBD domain point mutants","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP combined with in vitro binding and domain mutants, single lab with multiple methods","pmids":["20378711"],"is_preprint":false},{"year":2013,"finding":"MBD1 and Sp1-binding MCAF1 form a ternary complex; MCAF1 interacts with MBD1 via its TRD and with Sp1 separately. The MBD1-MCAF complex blocks Sp1-mediated transcription at methylated promoters.","method":"Co-immunoprecipitation; in vitro binding; reporter gene assays; MCAF1 knockdown rescue","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and reporter assays, confirmatory of earlier work (PMID:12665582), single lab","pmids":["23349673"],"is_preprint":false},{"year":2013,"finding":"MBD1 forms a complex with Twist and SIRT1 on the CDH1 (E-cadherin) promoter, resulting in reduced E-cadherin transcription and promotion of epithelial-mesenchymal transition in pancreatic cancer cells.","method":"Co-immunoprecipitation; ChIP; reporter assays; gain/loss-of-function","journal":"Current molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP and ChIP with functional readout, single lab study in cancer cells","pmids":["23331011"],"is_preprint":false},{"year":2013,"finding":"MBD1 is recruited to DNA damage sites and binds MDC1 (mediator of DNA damage checkpoint protein 1). MBD1 knockdown impairs DNA damage checkpoint activation and reduces DNA repair capacity, sensitizing cells to radiation and cisplatin.","method":"Co-immunoprecipitation; siRNA knockdown; DNA damage assays (gamma-H2AX); clonogenic survival assay","journal":"International journal of oncology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP identifying MDC1 as binding partner combined with KD and functional DNA damage readouts, single lab","pmids":["23588667"],"is_preprint":false},{"year":2014,"finding":"The transcriptional regulator Aire interacts with ATF7ip (MCAF1) and MBD1. Mbd1-knockout mice develop autoimmunity with a defect in Aire-dependent thymic expression of tissue-specific antigens, demonstrating that the ATF7ip-MBD1 complex is required for Aire's targeting of TSA loci.","method":"Co-immunoprecipitation; Mbd1 knockout mouse phenotyping; transcriptome analysis of thymic epithelial cells","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP combined with in vivo KO phenotype and mechanistic pathway placement","pmids":["24464130"],"is_preprint":false},{"year":2014,"finding":"ATF7IP-MBD1-SETDB1 pathway contributes to X chromosome inactivation maintenance. siRNA-mediated knockdown of Mbd1 or Setdb1, but not unrelated H3K9 methyltransferases, induces activation of silenced Xi-linked reporter genes in mouse embryonic fibroblasts, demonstrating functional specificity within the ATF7IP-MBD1-SETDB1 axis.","method":"siRNA knockdown; Xi-linked reporter gene reactivation assay; combined inhibition of multiple Xi maintenance pathways","journal":"Epigenetics & chromatin","confidence":"High","confidence_rationale":"Tier 2 / Strong — specific KD with reporter readout comparing multiple H3K9 methyltransferases, functional specificity demonstrated","pmids":["25028596"],"is_preprint":false},{"year":2014,"finding":"The C-terminal transcriptional repressor domain (TRD) of MBD1 (residues A529–P592) is intrinsically disordered. Despite lacking tertiary structure, it binds selectively to different partners: MPG and MCAF1 bind both N- and C-terminal residues of the TRD, whereas HDAC3 preferentially binds only the C-terminal region.","method":"NMR spectroscopy; protein-protein binding assays","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structural characterization with binding mapping, single lab but Tier 1 method","pmids":["24810720"],"is_preprint":false},{"year":2016,"finding":"MBD1 epigenetically silences KEAP1 in pancreatic cancer cells, and c-Myc is an MBD1 interaction partner in this silencing. MBD1 knockdown decreases antioxidant response and ARE-target gene expression through upregulation of KEAP1.","method":"Co-immunoprecipitation; ChIP; dual-luciferase reporter assay; siRNA knockdown","journal":"Current molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP, ChIP, and reporter assays in single lab study","pmids":["26980696"],"is_preprint":false},{"year":2017,"finding":"Mbd1 interacts with and enhances Tet1-mediated 5mC oxidation to 5hmC specifically at heterochromatic DNA in mammalian cells, dependent on the CXXC3 domain of Mbd1. The MBD-only isoform (lacking CXXC3) blocks Tet1-mediated 5mC oxidation, showing opposite effects of the two isoforms. Tet1 catalytic activity ultimately leads to displacement of Mbd1 from methylated DNA.","method":"Live-cell fluorescence imaging; flow cytometry for 5hmC; ChIP; overexpression of domain deletion mutants","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (imaging, 5hmC quantification, ChIP) with domain-deletion analysis in single focused study","pmids":["28449087"],"is_preprint":false},{"year":2018,"finding":"MBD1 represses Oprm1 (mu-opioid receptor) and Kcna2 gene expression in DRG neurons by recruiting DNA methyltransferase DNMT3a to their promoters. MBD1-deficient mice show reduced responses to acute noxious stimuli and blunted neuropathic pain; DRG-specific MBD1 overexpression restores these phenotypes.","method":"ChIP; MBD1 knockout mouse; DRG-specific overexpression via viral vector; behavioral pain assays","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — ChIP establishing DNMT3a recruitment, combined with KO and rescue/OE with specific behavioral readout","pmids":["30266739"],"is_preprint":false},{"year":2022,"finding":"MBD1 directly inhibits TET1-catalyzed 5mC oxidation kinetics via its MBD domain (which competes for mCpG binding), while the CXXC3 domain of MBD1 promotes TET1 oxidation kinetics by binding the unmethylated CpG product. The transcriptional repressor domain of MBD1 does not affect TET1 regulation, demonstrating distinct domain-specific contributions.","method":"Optochemical control of TET1 with photocaged serine; in vivo 5mC oxidation kinetics; MBD1 domain mutants","journal":"ACS chemical biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — innovative optochemical kinetic approach with domain mutant analysis, single lab but novel and rigorous method","pmids":["35709470"],"is_preprint":false},{"year":2022,"finding":"MBD1 directly represses miR-5701 expression together with HDAC3 by forming a complex that binds the miR-5701 promoter, which in turn regulates FGFR2 in gastric cancer cells.","method":"ChIP; co-immunoprecipitation; siRNA knockdown; luciferase reporter assay","journal":"Aging","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and Co-IP with reporter assay, single lab study","pmids":["35876658"],"is_preprint":false},{"year":2023,"finding":"MBD1 is essential for replication fork stability by recruiting PARP1 to stalled replication forks. Loss of MBD1 causes dissociation of PARP1 from forks, increased transcription-replication conflicts (T-R conflicts), elevated R-loops, accelerated fork progression, and DNA2-dependent degradation of stalled forks.","method":"Proximity ligation assay combined with EdU (iPOND); R-loop detection; DNA fiber assay; siRNA depletion; PARP1 co-immunoprecipitation","journal":"Cancer gene therapy","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (PLA-EdU, fiber assay, R-loop, Co-IP) in single focused study establishing PARP1 as binding partner at forks","pmids":["37949945"],"is_preprint":false},{"year":2024,"finding":"The MBD of human MBD1 binds preferentially to tandem (consecutive) symmetrically methylated CpG sites and DNA forks, with defined binding and dissociation rate constants measured at single-molecule level. This provides a mechanistic model for epigenetic boundary maintenance.","method":"Single-molecule kinetics (SiMKEPS) measuring rate constants on DNA substrates with varying CpG patterns and structural motifs","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — rigorous single-molecule in vitro assay but preprint, single lab, not yet peer-reviewed","pmids":[],"is_preprint":true},{"year":2025,"finding":"MBD1 is recruited to the Oprm1 promoter following peripheral nerve injury and recruits SUV39H1 to drive H3K9me3-mediated transcriptional silencing of Oprm1 in DRG neurons. Genetic ablation of MBD1 reversed injury-induced MOR downregulation, attenuated H3K9me3 enrichment at the Oprm1 promoter, and alleviated neuropathic pain despite persistent SUV39H1 upregulation.","method":"ChIP; MBD1 genetic knockout mouse; behavioral pain assays; western blot","journal":"Molecular pain","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP with KO genetic model and behavioral functional readout, extends PMID:30266739","pmids":["41090695"],"is_preprint":false},{"year":2025,"finding":"An MDS-associated long isoform of MBD1 (MBD1-L) arising from aberrant splicing switches MBD1's binding behavior from methylated to unmethylated CpGs, redirecting its heterochromatin-promoting activity and causing broad downregulation of CpG-rich promoters. MBD1-L overexpression in healthy HSPCs recapitulates MDS erythroid differentiation defects. Secondary epigenetic effects are mediated via downstream target BCOR.","method":"Isoform overexpression in human HSPCs; ChIP/ATAC-seq; antisense oligonucleotide depletion; differentiation assays","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple genomic and functional methods but preprint, single lab, not yet peer-reviewed","pmids":[],"is_preprint":true}],"current_model":"MBD1 is a methyl-CpG-binding domain protein that reads DNA methylation via its MBD domain and represses transcription through a C-terminal TRD by assembling context-specific complexes — including CAF-1/MBD1/SETDB1 (during replication-coupled chromatin assembly for H3K9me3 inheritance), MBD1·MCAF1·SETDB1 (for constitutive heterochromatin), MBD1·Suv39h1·HP1 (via the MBD), and HDAC3-MBD1 (recruited by PML-RARα) — while its CXXC3 domain additionally binds unmethylated CpG to enable methylation-independent repression; MBD1 SUMOylation by PIAS1/3 antagonizes SETDB1 recruitment and thus modulates silencing, its CXXC3 domain also promotes TET1-mediated 5mC oxidation at heterochromatin, and MBD1 maintains replication fork stability by recruiting PARP1 and limiting transcription-replication conflicts."},"narrative":{"mechanistic_narrative":"MBD1 is a methyl-CpG-binding transcriptional repressor that translates DNA methylation status into heritable chromatin silencing by reading methylated DNA through its MBD domain and assembling context-specific repressive complexes via a C-terminal transcriptional repression domain (TRD) [PMID:11371345, PMID:10648624, PMID:20378711]. The MBD folds into an alpha/beta sandwich that recognizes methyl groups and CG sequence through a conserved hydrophobic patch, and is necessary and sufficient for targeting MBD1 to methylated loci; it preferentially engages tandem symmetrically methylated CpG sites [PMID:11371345, PMID:10581239, PMID:20378711]. Alternative splicing generates CXXC3-containing isoforms that additionally bind unmethylated CpG, enabling methylation-independent repression and heterochromatin localization [PMID:10454587, PMID:10866667, PMID:15060159]. Silencing is enacted by recruiting histone-modifying machinery: MBD1 couples H3K9 methylation to histone deacetylation through Suv39h1/HP1 and through HDAC3, and assembles an MBD1·MCAF1(ATF7IP)·SETDB1 complex required for heterochromatin formation, including an S-phase CAF-1/MBD1/SETDB1 complex that propagates H3K9 methylation during replication-coupled chromatin assembly [PMID:10648624, PMID:12711603, PMID:12665582, PMID:15327775, PMID:15691849, PMID:24810720]. SUMOylation of MBD1 by PIAS1/3 antagonizes SETDB1 recruitment, providing a switch that modulates the silencing output [PMID:17066076]. Through these activities MBD1 maintains X-inactivation and Aire-dependent thymic tolerance, and directs neural and neuronal gene programs by repressing Fgf-2, miR-184, and Oprm1 via DNA-methylation-dependent and DNMT3a/SUV39H1-coupled mechanisms [PMID:18689796, PMID:20452318, PMID:24464130, PMID:25028596, PMID:30266739, PMID:41090695]. Beyond transcription, MBD1 acts at the replication fork, recruiting PARP1 to stabilize stalled forks and limit transcription-replication conflicts, and its CXXC3 domain tunes TET1-mediated 5mC oxidation at heterochromatin [PMID:28449087, PMID:35709470, PMID:37949945].","teleology":[{"year":1999,"claim":"Establishing how MBD1 physically reads its substrate, the free and methylated-DNA-bound MBD structures defined the alpha/beta-sandwich fold and the conserved residues that recognize methyl-CpG, providing the structural basis for methylation reading.","evidence":"NMR solution structures of free and methylated-DNA-bound MBD with site-directed mutagenesis","pmids":["10581239","11371345"],"confidence":"High","gaps":["Structures of full-length MBD1 or its complexes not determined","Does not address how MBD selectivity is tuned across genomic contexts"]},{"year":1999,"claim":"Discovery that alternative splicing produces CXXC3-containing isoforms binding unmethylated DNA showed MBD1 represses both methylated and unmethylated promoters through distinct domains, revealing two parallel targeting modes.","evidence":"GFP-isoform transfection in methylation-deficient and mammalian cells, reporter assays, EMSA","pmids":["10454587","10866667"],"confidence":"High","gaps":["Relative in vivo contributions of MBD vs CXXC3 targeting not resolved here","Tissue-specific isoform usage unknown"]},{"year":2000,"claim":"Mapping the C-terminal TRD and its HDAC-inhibitor sensitivity established MBD1 as an active repressor dependent on histone deacetylation, distinct from the MeCP1 complex.","evidence":"Reporter assays, trichostatin A treatment, immunofluorescence, co-immunoprecipitation","pmids":["10648624"],"confidence":"High","gaps":["Direct deacetylase partner not identified at this stage","Mechanism of repression at a distance unexplained"]},{"year":2003,"claim":"Identification of Suv39h1/HP1, CAF-1 p150, and the MCAF mediator as MBD1 partners explained how MBD1 couples DNA methylation reading to H3K9 methylation, heterochromatin, and Sp1-blocking repression.","evidence":"GST pulldown, reciprocal Co-IP, yeast two-hybrid, immunofluorescence colocalization, dominant-negative overexpression, reporter assays","pmids":["12711603","12697822","12665582"],"confidence":"High","gaps":["How these complexes are temporally coordinated not yet defined","Stoichiometry and exclusivity of complexes unknown"]},{"year":2004,"claim":"The S-phase-specific CAF-1/MBD1/SETDB1 complex showed MBD1 propagates H3K9 methylation during replication-coupled chromatin assembly, linking methylation maintenance to chromatin inheritance.","evidence":"Co-IP, ChIP, siRNA knockdown, S-phase cell fractionation","pmids":["15327775"],"confidence":"High","gaps":["Direct demonstration of mark inheritance across generations not shown","Genome-wide scope of affected loci limited"]},{"year":2004,"claim":"Demonstrating that CXXC3 binds nonmethylated CpG in vivo clarified the basis for methylation-independent heterochromatin localization and repression of unmethylated targets.","evidence":"Domain-mutant transfection, DNA binding assays, fluorescence microscopy in methylation-deficient cells","pmids":["15060159"],"confidence":"High","gaps":["Endogenous nonmethylated targets not catalogued","Interplay with MBD-based targeting unresolved"]},{"year":2005,"claim":"Defining MCAF1/MCAF2 as bridging factors linking MBD1, SETDB1, and Sp1 established the MBD1·MCAF1·SETDB1 complex as the core machinery for heterochromatic domain formation.","evidence":"Co-IP, in vitro binding, siRNA knockdown, immunofluorescence with domain mutants, reporter assays","pmids":["15691849"],"confidence":"High","gaps":["Distinct roles of MCAF1 vs MCAF2 not separated","Recruitment hierarchy at native loci unclear"]},{"year":2006,"claim":"Discovery of SUMOylation by PIAS1/3 and SUMO-dependent MCAF1 binding revealed a post-translational switch controlling whether MBD1 assembles the repressive SETDB1 complex.","evidence":"In vivo sumoylation assays, site-directed mutagenesis of acceptor lysines, Co-IP, siRNA knockdown, reporter assays, immunofluorescence","pmids":["17066076","16757475"],"confidence":"High","gaps":["Signals controlling MBD1 SUMOylation dynamics unknown","How SUMO simultaneously blocks SETDB1 yet aids MCAF1 binding is mechanistically unreconciled"]},{"year":2006,"claim":"Placing an HDAC3-MBD1 complex downstream of PML-RARalpha connected MBD1 to oncogenic transcriptional silencing and a block to hematopoietic differentiation.","evidence":"ChIP, siRNA knockdown, dominant-negative MBD1 expression, differentiation assays","pmids":["16432238"],"confidence":"High","gaps":["Direct MBD1-HDAC3 contact details limited","Generality beyond PML-RARalpha targets not tested"]},{"year":2007,"claim":"Linking MBD1 to PRC1 components Ring1b and hPc2 via its CXXC domains extended MBD1 silencing to Polycomb-controlled HOXA loci.","evidence":"Co-IP, ChIP, siRNA knockdown, domain-mutant immunofluorescence, 5-azadeoxycytidine treatment","pmids":["17428788"],"confidence":"High","gaps":["Direct vs indirect nature of PRC1 association not fully resolved","Genome-wide overlap with Polycomb domains undefined"]},{"year":2008,"claim":"Identifying Mbd1 repression of Fgf-2 in adult neural stem cells assigned MBD1 a physiological role in neuronal differentiation via methylation-dependent silencing.","evidence":"ChIP, bisulfite sequencing, methylation inhibitor, siRNA knockdown, overexpression in NSPCs","pmids":["18689796"],"confidence":"High","gaps":["How Mbd1 loss leads to promoter hypomethylation not explained","Full neural target set not defined"]},{"year":2010,"claim":"The MBD1→miR-184→Numbl axis and refined ChIP/in vitro mapping established that the MBD domain is the principal in vivo targeting determinant and that MBD1 controls neural stem cell fate through a miRNA circuit.","evidence":"ChIP, luciferase 3'-UTR reporters, miRNA gain/loss, rescue experiments, in vitro domain binding, MBD point mutants","pmids":["20452318","20378711"],"confidence":"High","gaps":["When CXXC3 targeting becomes functionally relevant remains unclear","Broader miRNA targets of MBD1 not surveyed"]},{"year":2013,"claim":"Showing the TRD is intrinsically disordered yet binds distinct partners (MPG, MCAF1, HDAC3) explained how a single repression module recruits multiple effectors.","evidence":"NMR spectroscopy and protein-protein binding mapping","pmids":["24810720"],"confidence":"High","gaps":["Conformational states upon binding not resolved","Functional consequence of competitive partner binding untested"]},{"year":2014,"claim":"In vivo knockout studies placed the ATF7IP-MBD1-SETDB1 axis in Aire-dependent thymic tolerance and X-inactivation maintenance, demonstrating MBD1's role in organismal epigenetic silencing programs.","evidence":"Co-IP, Mbd1 knockout mouse phenotyping and thymic transcriptomics, Xi-linked reporter reactivation with pathway-specific knockdowns","pmids":["24464130","25028596"],"confidence":"High","gaps":["Direct chromatin targets at Xi and TSA loci incompletely mapped","Whether the same complex operates at both contexts is not directly compared"]},{"year":2013,"claim":"Cancer-context studies linked MBD1 to EMT and antioxidant control by forming repressive complexes (Twist/SIRT1 at CDH1; c-Myc at KEAP1) at specific promoters.","evidence":"Co-IP, ChIP, reporter assays, gain/loss-of-function in cancer cells","pmids":["23331011","26980696"],"confidence":"Medium","gaps":["Single-lab studies without reciprocal validation across systems","Direct vs indirect promoter occupancy not always resolved"]},{"year":2017,"claim":"Demonstrating opposite domain-specific effects on TET1 — MBD inhibiting and CXXC3 promoting 5mC oxidation — recast MBD1 as an active modulator of DNA demethylation at heterochromatin rather than a passive reader.","evidence":"Live-cell imaging, 5hmC flow cytometry, ChIP, domain-deletion mutants; optochemical TET1 kinetics with domain mutants","pmids":["28449087","35709470"],"confidence":"High","gaps":["In vivo balance between the two isoforms genome-wide unknown","Physiological loci where TET1 modulation matters not defined"]},{"year":2018,"claim":"Linking MBD1 to DNMT3a recruitment at Oprm1/Kcna2 and later to SUV39H1-driven H3K9me3 silencing established MBD1 as a driver of injury-induced gene silencing underlying neuropathic pain.","evidence":"ChIP, MBD1 knockout mice, DRG-specific viral overexpression/rescue, behavioral pain assays, western blot","pmids":["30266739","41090695"],"confidence":"High","gaps":["How MBD1 is recruited after nerve injury not fully mechanistic","Relative contributions of DNMT3a vs SUV39H1 arms not dissected"]},{"year":2013,"claim":"Finding MBD1 at DNA damage sites bound to MDC1 and required for checkpoint activation extended its function into the DNA damage response.","evidence":"Co-IP, siRNA knockdown, gamma-H2AX assays, clonogenic survival","pmids":["23588667"],"confidence":"Medium","gaps":["Single Co-IP without reciprocal validation of MDC1 interaction","Whether recruitment depends on chromatin reading is unclear"]},{"year":2023,"claim":"Identifying MBD1 as a PARP1-recruiting factor that stabilizes stalled replication forks and limits transcription-replication conflicts defined a non-transcriptional genome-maintenance role.","evidence":"iPOND/PLA-EdU, R-loop detection, DNA fiber assays, siRNA depletion, PARP1 Co-IP","pmids":["37949945"],"confidence":"High","gaps":["How MBD1 selects stalled forks mechanistically unknown","Relationship to its transcriptional silencing functions not integrated"]},{"year":2024,"claim":"Single-molecule kinetics showed the MBD prefers tandem symmetric methyl-CpG and DNA forks, offering a model for epigenetic boundary maintenance.","evidence":"SiMKEPS single-molecule rate-constant measurements (preprint) on varied CpG/structural substrates","pmids":[],"confidence":"Medium","gaps":["Preprint, not yet peer-reviewed","In vitro kinetics not validated against in vivo occupancy"]},{"year":2025,"claim":"Characterizing an MDS-associated long isoform that switches MBD1 from methylated to unmethylated CpG binding linked aberrant splicing of MBD1 to a hematopoietic differentiation disease phenotype via BCOR.","evidence":"Isoform overexpression in human HSPCs, ChIP/ATAC-seq, antisense depletion, differentiation assays (preprint)","pmids":[],"confidence":"Medium","gaps":["Preprint, not yet peer-reviewed","Causal role of MBD1-L in patient disease not established"]},{"year":null,"claim":"How MBD1's distinct functional modes — methylation-dependent silencing, methylation-independent CXXC3 targeting, TET1 modulation, and replication-fork protection — are coordinated within a cell and across the cell cycle remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No integrated model linking transcriptional and replication-fork roles","Genome-wide isoform- and modification-state-resolved occupancy lacking","Structure of full-length MBD1 or its native complexes undetermined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,1,2,8,17,30]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[2,3,6,7,9]},{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[25,27]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[3,5,10]},{"term_id":"GO:0000228","term_label":"nuclear chromosome","supporting_discovery_ids":[3,5,7]}],"pathway":[{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[4,7,9,22]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[3,6,15,16,26]},{"term_id":"R-HSA-69306","term_label":"DNA Replication","supporting_discovery_ids":[7,29]},{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[20,29]}],"complexes":["CAF-1/MBD1/SETDB1","MBD1·MCAF1(ATF7IP)·SETDB1","MBD1·Suv39h1·HP1","HDAC3-MBD1"],"partners":["SETDB1","MCAF1","SUV39H1","HP1","CAF-1 P150","HDAC3","PARP1","PIAS1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9UIS9","full_name":"Methyl-CpG-binding domain protein 1","aliases":["CXXC-type zinc finger protein 3","Methyl-CpG-binding protein MBD1","Protein containing methyl-CpG-binding domain 1"],"length_aa":605,"mass_kda":66.6,"function":"Transcriptional repressor that binds CpG islands in promoters where the DNA is methylated at position 5 of cytosine within CpG dinucleotides. Binding is abolished by the presence of 7-mG that is produced by DNA damage by methylmethanesulfonate (MMS). Acts as transcriptional repressor and plays a role in gene silencing by recruiting ATF7IP, which in turn recruits factors such as the histone methyltransferase SETDB1. Probably forms a complex with SETDB1 and ATF7IP that represses transcription and couples DNA methylation and histone 'Lys-9' trimethylation. Isoform 1 and isoform 2 can also repress transcription from unmethylated promoters","subcellular_location":"Nucleus; Nucleus matrix; Nucleus speckle; Chromosome","url":"https://www.uniprot.org/uniprotkb/Q9UIS9/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MBD1","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"PARP1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/MBD1","total_profiled":1310},"omim":[{"mim_id":"613880","title":"BROMO-ADJACENT HOMOLOGY DOMAIN-CONTAINING PROTEIN 1; BAHD1","url":"https://www.omim.org/entry/613880"},{"mim_id":"613645","title":"ACTIVATING TRANSCRIPTION FACTOR 7-INTERACTING PROTEIN 2; ATF7IP2","url":"https://www.omim.org/entry/613645"},{"mim_id":"613644","title":"ACTIVATING TRANSCRIPTION FACTOR 7-INTERACTING PROTEIN; ATF7IP","url":"https://www.omim.org/entry/613644"},{"mim_id":"605166","title":"HISTONE DEACETYLASE 3; HDAC3","url":"https://www.omim.org/entry/605166"},{"mim_id":"605077","title":"DNA METHYLTRANSFERASE 1-ASSOCIATED PROTEIN 1; DMAP1","url":"https://www.omim.org/entry/605077"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MBD1"},"hgnc":{"alias_symbol":["PCM1","CXXC3"],"prev_symbol":[]},"alphafold":{"accession":"Q9UIS9","domains":[{"cath_id":"3.30.890.10","chopping":"6-70","consensus_level":"high","plddt":92.5717,"start":6,"end":70},{"cath_id":"-","chopping":"132-222","consensus_level":"medium","plddt":79.0596,"start":132,"end":222},{"cath_id":"-","chopping":"335-388","consensus_level":"medium","plddt":90.1593,"start":335,"end":388}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UIS9","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UIS9-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9UIS9-F1-predicted_aligned_error_v6.png","plddt_mean":59.91},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MBD1","jax_strain_url":"https://www.jax.org/strain/search?query=MBD1"},"sequence":{"accession":"Q9UIS9","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9UIS9.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9UIS9/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9UIS9"}},"corpus_meta":[{"pmid":"15327775","id":"PMC_15327775","title":"Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly.","date":"2004","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/15327775","citation_count":353,"is_preprint":false},{"pmid":"20452318","id":"PMC_20452318","title":"Epigenetic regulation of miR-184 by MBD1 governs neural stem cell proliferation and differentiation.","date":"2010","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/20452318","citation_count":263,"is_preprint":false},{"pmid":"11371345","id":"PMC_11371345","title":"Solution structure of the methyl-CpG binding domain of human MBD1 in complex with methylated DNA.","date":"2001","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/11371345","citation_count":252,"is_preprint":false},{"pmid":"12711603","id":"PMC_12711603","title":"Methyl-CpG binding domain 1 (MBD1) interacts with the Suv39h1-HP1 heterochromatic complex for DNA methylation-based transcriptional repression.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12711603","citation_count":209,"is_preprint":false},{"pmid":"10648624","id":"PMC_10648624","title":"Active repression of methylated genes by the chromosomal protein MBD1.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10648624","citation_count":208,"is_preprint":false},{"pmid":"10454587","id":"PMC_10454587","title":"Methylation-mediated transcriptional silencing in euchromatin by methyl-CpG binding protein MBD1 isoforms.","date":"1999","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10454587","citation_count":165,"is_preprint":false},{"pmid":"15060159","id":"PMC_15060159","title":"Mbd1 is recruited to both methylated and nonmethylated CpGs via distinct DNA binding domains.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15060159","citation_count":139,"is_preprint":false},{"pmid":"10866667","id":"PMC_10866667","title":"Mechanism of transcriptional regulation by methyl-CpG binding protein MBD1.","date":"2000","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10866667","citation_count":138,"is_preprint":false},{"pmid":"16670375","id":"PMC_16670375","title":"Fluoxetine and cocaine induce the epigenetic factors MeCP2 and MBD1 in adult rat brain.","date":"2006","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/16670375","citation_count":134,"is_preprint":false},{"pmid":"15691849","id":"PMC_15691849","title":"Transcriptional repression and heterochromatin formation by MBD1 and MCAF/AM family proteins.","date":"2005","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15691849","citation_count":107,"is_preprint":false},{"pmid":"10581239","id":"PMC_10581239","title":"Solution structure of the methyl-CpG-binding domain of the methylation-dependent transcriptional repressor MBD1.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/10581239","citation_count":100,"is_preprint":false},{"pmid":"10441743","id":"PMC_10441743","title":"Genomic structure and chromosomal mapping of the murine and human Mbd1, Mbd2, Mbd3, and Mbd4 genes.","date":"1999","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/10441743","citation_count":90,"is_preprint":false},{"pmid":"16432238","id":"PMC_16432238","title":"The methyl-CpG binding protein MBD1 is required for PML-RARalpha function.","date":"2006","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/16432238","citation_count":84,"is_preprint":false},{"pmid":"18689796","id":"PMC_18689796","title":"Epigenetic regulation of the stem cell mitogen Fgf-2 by Mbd1 in adult neural stem/progenitor cells.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18689796","citation_count":82,"is_preprint":false},{"pmid":"16757475","id":"PMC_16757475","title":"Involvement of SUMO modification in MBD1- and MCAF1-mediated heterochromatin formation.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16757475","citation_count":79,"is_preprint":false},{"pmid":"12697822","id":"PMC_12697822","title":"The methyl-CpG binding protein MBD1 interacts with the p150 subunit of chromatin assembly factor 1.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12697822","citation_count":78,"is_preprint":false},{"pmid":"12665582","id":"PMC_12665582","title":"MCAF mediates MBD1-dependent transcriptional repression.","date":"2003","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/12665582","citation_count":77,"is_preprint":false},{"pmid":"24464130","id":"PMC_24464130","title":"The transcriptional regulator Aire coopts the repressive ATF7ip-MBD1 complex for the induction of immunotolerance.","date":"2014","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/24464130","citation_count":73,"is_preprint":false},{"pmid":"25028596","id":"PMC_25028596","title":"The Mbd1-Atf7ip-Setdb1 pathway contributes to the maintenance of X chromosome inactivation.","date":"2014","source":"Epigenetics & chromatin","url":"https://pubmed.ncbi.nlm.nih.gov/25028596","citation_count":71,"is_preprint":false},{"pmid":"20378711","id":"PMC_20378711","title":"Recruitment of MBD1 to target genes requires sequence-specific interaction of the MBD domain with methylated DNA.","date":"2010","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/20378711","citation_count":70,"is_preprint":false},{"pmid":"15777793","id":"PMC_15777793","title":"The intracellular domain of teneurin-1 interacts with MBD1 and CAP/ponsin resulting in subcellular codistribution and translocation to the nuclear matrix.","date":"2005","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/15777793","citation_count":57,"is_preprint":false},{"pmid":"30266739","id":"PMC_30266739","title":"MBD1 Contributes to the Genesis of Acute Pain and Neuropathic Pain by Epigenetic Silencing of Oprm1 and Kcna2 Genes in Primary Sensory Neurons.","date":"2018","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30266739","citation_count":51,"is_preprint":false},{"pmid":"23349673","id":"PMC_23349673","title":"An epigenetic feedback regulatory loop involving microRNA-195 and MBD1 governs neural stem cell differentiation.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23349673","citation_count":50,"is_preprint":false},{"pmid":"23331011","id":"PMC_23331011","title":"Up-regulation of MBD1 promotes pancreatic cancer cell epithelial-mesenchymal transition and invasion by epigenetic down-regulation of E-cadherin.","date":"2013","source":"Current molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23331011","citation_count":49,"is_preprint":false},{"pmid":"17066076","id":"PMC_17066076","title":"Regulation of MBD1-mediated transcriptional repression by SUMO and PIAS proteins.","date":"2006","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17066076","citation_count":48,"is_preprint":false},{"pmid":"18752820","id":"PMC_18752820","title":"Enhanced expression of murine beta-defensins (MBD-1, -2,- 3, and -4) in upper and lower airway mucosa of influenza virus infected mice.","date":"2008","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/18752820","citation_count":48,"is_preprint":false},{"pmid":"25751725","id":"PMC_25751725","title":"An epigenetic regulator: methyl-CpG-binding domain protein 1 (MBD1).","date":"2015","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25751725","citation_count":40,"is_preprint":false},{"pmid":"17428788","id":"PMC_17428788","title":"Overlapping roles of the methylated DNA-binding protein MBD1 and polycomb group proteins in transcriptional repression of HOXA genes and heterochromatin foci formation.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17428788","citation_count":33,"is_preprint":false},{"pmid":"12646234","id":"PMC_12646234","title":"Methyl-CpG-DNA binding proteins in human prostate cancer: expression of CXXC sequence containing MBD1 and repression of MBD2 and MeCP2.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12646234","citation_count":33,"is_preprint":false},{"pmid":"19276660","id":"PMC_19276660","title":"RNA interference of MBD1 in BxPC-3 human pancreatic cancer cells delivered by PLGA-poloxamer nanoparticles.","date":"2009","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/19276660","citation_count":32,"is_preprint":false},{"pmid":"28100736","id":"PMC_28100736","title":"Methyl-CpG-Binding Protein MBD1 Regulates Neuronal Lineage Commitment through Maintaining Adult Neural Stem Cell Identity.","date":"2017","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28100736","citation_count":29,"is_preprint":false},{"pmid":"28449087","id":"PMC_28449087","title":"Methyl-CpG binding domain protein 1 regulates localization and activity of Tet1 in a CXXC3 domain-dependent manner.","date":"2017","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/28449087","citation_count":27,"is_preprint":false},{"pmid":"12776203","id":"PMC_12776203","title":"MBD1, MBD2 and CGBP genes at chromosome 18q21 are infrequently mutated in human colon and lung cancers.","date":"2003","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/12776203","citation_count":27,"is_preprint":false},{"pmid":"23588667","id":"PMC_23588667","title":"Silencing of MBD1 reverses pancreatic cancer therapy resistance through inhibition of DNA damage repair.","date":"2013","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23588667","citation_count":26,"is_preprint":false},{"pmid":"11738867","id":"PMC_11738867","title":"Regulation of transcription and chromatin by methyl-CpG binding protein MBD1.","date":"2001","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/11738867","citation_count":23,"is_preprint":false},{"pmid":"32469064","id":"PMC_32469064","title":"NR2F2-AS1 accelerates cell proliferation through regulating miR-4429/MBD1 axis in cervical cancer.","date":"2020","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/32469064","citation_count":18,"is_preprint":false},{"pmid":"26980696","id":"PMC_26980696","title":"MBD1 is an Epigenetic Regulator of KEAP1 in Pancreatic Cancer.","date":"2016","source":"Current molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26980696","citation_count":16,"is_preprint":false},{"pmid":"18445260","id":"PMC_18445260","title":"Proteomic analysis of differential proteins in pancreatic carcinomas: Effects of MBD1 knock-down by stable RNA interference.","date":"2008","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/18445260","citation_count":15,"is_preprint":false},{"pmid":"24632574","id":"PMC_24632574","title":"Construction of eukaryotic expression vector with mBD1-mBD3 fusion genes and exploring its activity against influenza A virus.","date":"2014","source":"Viruses","url":"https://pubmed.ncbi.nlm.nih.gov/24632574","citation_count":13,"is_preprint":false},{"pmid":"24810720","id":"PMC_24810720","title":"Transcriptional repressor domain of MBD1 is intrinsically disordered and interacts with its binding partners in a selective manner.","date":"2014","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/24810720","citation_count":12,"is_preprint":false},{"pmid":"31516389","id":"PMC_31516389","title":"MBD1 promotes the malignant behavior of gallbladder cancer cells and induces chemotherapeutic resistance to gemcitabine.","date":"2019","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/31516389","citation_count":9,"is_preprint":false},{"pmid":"25658035","id":"PMC_25658035","title":"Molecular dynamics study of the recognition of dimethylated CpG sites by MBD1 protein.","date":"2015","source":"Journal of chemical information and modeling","url":"https://pubmed.ncbi.nlm.nih.gov/25658035","citation_count":9,"is_preprint":false},{"pmid":"35876658","id":"PMC_35876658","title":"MBD1/HDAC3-miR-5701-FGFR2 axis promotes the development of gastric cancer.","date":"2022","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/35876658","citation_count":7,"is_preprint":false},{"pmid":"37434830","id":"PMC_37434830","title":"LncRNA SNHG20 silencing inhibits hepatocellular carcinoma progression by sponging miR-5095 from MBD1.","date":"2023","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/37434830","citation_count":5,"is_preprint":false},{"pmid":"35709470","id":"PMC_35709470","title":"Optochemical Control of TET Dioxygenases Enables Kinetic Insights into the Domain-Dependent Interplay of TET1 and MBD1 while Oxidizing and Reading 5-Methylcytosine.","date":"2022","source":"ACS chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/35709470","citation_count":4,"is_preprint":false},{"pmid":"22583687","id":"PMC_22583687","title":"A semi-quantitative assay of overall DNA methylation status using Methyl-CpG binding protein (MBD1).","date":"2012","source":"BMC research notes","url":"https://pubmed.ncbi.nlm.nih.gov/22583687","citation_count":4,"is_preprint":false},{"pmid":"36574452","id":"PMC_36574452","title":"Forward genetic screen of homeostatic antibody levels in the Collaborative Cross identifies MBD1 as a novel regulator of B cell homeostasis.","date":"2022","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/36574452","citation_count":4,"is_preprint":false},{"pmid":"19062732","id":"PMC_19062732","title":"[Activation of multiple tumor suppressor genes by MBD1 siRNA in pancreatic cancer cell line BxPC-3].","date":"2008","source":"Zhonghua yi xue za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/19062732","citation_count":3,"is_preprint":false},{"pmid":"37949945","id":"PMC_37949945","title":"MBD1 protects replication fork stability by recruiting PARP1 and controlling transcription-replication conflicts.","date":"2023","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/37949945","citation_count":2,"is_preprint":false},{"pmid":"28669357","id":"PMC_28669357","title":"MBD1 and MeCP2 expression in embryos and placentas from transgenic cloned goats.","date":"2017","source":"Zygote (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28669357","citation_count":0,"is_preprint":false},{"pmid":"16696318","id":"PMC_16696318","title":"Effect of antisense MBD1 gene eukaryotic expression plasmid on expression of MBD1 gene in human biliary tract carcinoma cells.","date":"2005","source":"Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban","url":"https://pubmed.ncbi.nlm.nih.gov/16696318","citation_count":0,"is_preprint":false},{"pmid":"41090695","id":"PMC_41090695","title":"MBD1-dependent recruitment of SUV39h1 induces H3K9me3-mediated transcriptional silencing of Oprm1 in dorsal root ganglia after peripheral nerve injury.","date":"2025","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/41090695","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.17.682569","title":"Aberrant splicing of  <i>MBD1</i>  reshapes the epigenome to drive convergent myeloerythroid defects in MDS","date":"2025-10-19","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.17.682569","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.03.13.643172","title":"DNA replication stress-induced transcriptome of Human Burkitt’s lymphoma identifies MBD1 as a novel suppressor of  <i>BCL6</i>  rearrangements in germinal center derived B-lymphomagenesis","date":"2025-03-15","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.13.643172","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.02.25.640188","title":"The Kinesin-14 Tail: Dual microtubule binding domains drive spindle morphogenesis through tight microtubule cross-linking and robust sliding","date":"2025-02-26","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.25.640188","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.09.22.614380","title":"Mechanistic model for epigenetic maintenance by methyl-CpG-binding domain proteins","date":"2024-09-24","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.22.614380","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.08.31.609994","title":"Distal super-enhancer drives aberrant  <i>CXCL13</i>  expression in Cancer cells driving growth and p53 dysregulation via CXCR5-CXCL13 axis","date":"2024-09-03","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.31.609994","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":30255,"output_tokens":8114,"usd":0.106237,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17500,"output_tokens":6363,"usd":0.123287,"stage2_stop_reason":"end_turn"},"total_usd":0.229524,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2001,\n      \"finding\": \"Solution structure of the MBD of human MBD1 bound to methylated DNA was determined by NMR. DNA binding causes a loop in MBD1 to fold into a novel DNA binding interface; recognition of methyl groups and CG sequence is mediated by five highly conserved residues forming a hydrophobic patch (including Asp32, Tyr34, Arg44).\",\n      \"method\": \"Multi-dimensional heteronuclear NMR spectroscopy with site-directed mutagenesis\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — atomic-resolution NMR structure with mutagenesis validation, replicated by earlier unbound MBD structure (PMID:10581239)\",\n      \"pmids\": [\"11371345\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Solution structure of the free MBD of human MBD1 determined by NMR; it folds into an alpha/beta-sandwich with a large positively charged surface identified as the DNA interaction site. Conserved residues Tyr34, Asp32, and three basic residues are critical for DNA binding, established by site-directed mutagenesis and chemical shift mapping.\",\n      \"method\": \"Multi-dimensional heteronuclear NMR spectroscopy with site-directed mutagenesis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — atomic-resolution NMR structure with mutagenesis validation in a focused mechanistic study\",\n      \"pmids\": [\"10581239\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"MBD1 possesses isoforms (v1/v2 with CXXC1-3; v3/v4 with CXXC1-2) due to alternative splicing. The CXXC3 domain in isoforms v1/v2 confers binding to unmethylated DNA and transcriptional repression of unmethylated promoters, whereas the MBD confers methylation-dependent repression. Both the MBD and CXXC domains, plus the C-terminal TRD, cooperate for transcriptional regulation.\",\n      \"method\": \"Transfection of GFP-fused isoforms in methylation-deficient Drosophila SL2 and mammalian CHO-K1 cells; reporter assays; EMSA with bacterially expressed domains\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple isoforms tested with domain mutants, reporter assays, and DNA binding in two cell systems; replicated across multiple papers\",\n      \"pmids\": [\"10454587\", \"10866667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"MBD1 contains a powerful C-terminal transcriptional repression domain (TRD) that actively represses transcription at a distance. Methylation-dependent repression in vivo requires both the TRD and the MBD. Repression is sensitive to trichostatin A (HDAC inhibitor), indicating dependence on histone deacetylation. Endogenous MBD1 concentrates at centromeric heterochromatin where acetylated H4 is deficient. MBD1 is not a component of the MeCP1 complex.\",\n      \"method\": \"Transient transfection reporter assays; trichostatin A treatment; immunofluorescence localization; co-immunoprecipitation (negative for MeCP1)\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (reporter assays, pharmacological inhibition, localization), replicated in subsequent work\",\n      \"pmids\": [\"10648624\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"MBD1 directly interacts with histone H3 methylase Suv39h1 and methyl-lysine binding protein HP1 via its MBD in vitro and in cells. Suv39h1 enhances MBD1-mediated transcriptional repression through the MBD (not the TRD). MBD1 links to HDACs through Suv39h1, resulting in coupled H3K9 methylation and histone deacetylation for gene inactivation.\",\n      \"method\": \"In vitro GST pulldown; co-immunoprecipitation; reporter gene assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP and in vitro pulldown with functional reporter assays; replicated in subsequent studies\",\n      \"pmids\": [\"12711603\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"MBD1 interacts with the p150 subunit of chromatin assembly factor 1 (CAF-1), forming a multiprotein complex that also contains HP1alpha. The interaction requires the MBD of MBD1 and maps to the C-terminus of CAF-1 p150. Overexpression of the CAF-1 p150 C-terminus displaces MBD1 from heterochromatic foci without disrupting global heterochromatin structure.\",\n      \"method\": \"Co-immunoprecipitation; immunofluorescence colocalization; dominant-negative overexpression\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP with domain mapping, localization studies, and functional dominant-negative experiment; confirmed in PMID:15327775\",\n      \"pmids\": [\"12697822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"A mediator protein MCAF (MBD1-containing chromatin-associated factor) interacts with the TRD of MBD1, identified by yeast two-hybrid. MCAF interacts with both MBD1 and the transcription factor Sp1. The MBD1-MCAF complex blocks transcription through Sp1 on methylated promoters via a histone deacetylation-resistant mechanism.\",\n      \"method\": \"Yeast two-hybrid; co-immunoprecipitation; reporter gene assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — yeast two-hybrid identification confirmed by Co-IP and reporter assays; expanded in PMID:15691849\",\n      \"pmids\": [\"12665582\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"MBD1 forms a stable complex with histone H3K9 methylase SETDB1. During S phase, MBD1 recruits SETDB1 to the CAF-1 p150 subunit to form an S phase-specific CAF-1/MBD1/SETDB1 complex that facilitates H3K9 methylation during replication-coupled chromatin assembly. Absence of MBD1 causes loss of H3K9 methylation at multiple genomic loci and derepression of p53BP2.\",\n      \"method\": \"Co-immunoprecipitation; ChIP; siRNA knockdown; cell fractionation during S phase\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (Co-IP, ChIP, KD with gene expression readout), replicated by independent studies\",\n      \"pmids\": [\"15327775\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Mouse Mbd1 isoform Mbd1a contains a CXXC3 domain that binds specifically to nonmethylated CpG sites in vivo and in vitro, explaining methylation-independent heterochromatin localization. CXXC3-mediated targeting is responsible for repression of nonmethylated reporter genes, while MBD-mediated binding is required for repression of methylated reporters.\",\n      \"method\": \"Transfection studies with domain mutants; DNA binding assays; fluorescence microscopy in methylation-deficient mouse cells\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — domain dissection with in vivo targeting and reporter assays; convergent with PMID:10866667\",\n      \"pmids\": [\"15060159\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MCAF1 (ATF7ip/AM) is required for transcriptional repression and heterochromatin formation by MBD1, together with SETDB1. Both MCAF1 and a newly identified MCAF2 interact with MBD1, SETDB1, and Sp1 via two conserved distinct domains. An MBD1 mutant lacking MCAF interaction perturbs HP1-enriched heterochromatin formation, establishing the MBD1·MCAF1·SETDB1 complex as required for heterochromatic domain formation.\",\n      \"method\": \"Co-immunoprecipitation; in vitro binding; siRNA knockdown; immunofluorescence; reporter assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods including KD rescue and domain-mutant localization studies\",\n      \"pmids\": [\"15691849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"The intracellular domain of teneurin-1 interacts with MBD1 and co-localizes with it in nuclear matrix-associated foci, identified by yeast two-hybrid and validated by co-transfection and co-localization studies.\",\n      \"method\": \"Yeast two-hybrid; co-transfection; co-localization immunofluorescence; nuclear fractionation\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — yeast two-hybrid confirmed by co-localization but no functional consequence of the interaction established\",\n      \"pmids\": [\"15777793\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"MBD1 is SUMOylated at two conserved C-terminal lysine residues by PIAS1 and PIAS3 E3 SUMO ligases. Sumoylated MBD1 can still bind methylated DNA but fails to form a complex with SETDB1 and cannot efficiently repress target gene p53BP2, indicating that SUMO conjugation antagonizes formation of the repressive MBD1-SETDB1 complex.\",\n      \"method\": \"In vivo sumoylation assay; co-immunoprecipitation; reporter gene assay; site-directed mutagenesis of SUMO acceptor lysines\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — mutagenesis of modification sites combined with Co-IP and functional reporter assay in single study with multiple methods\",\n      \"pmids\": [\"17066076\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"SUMOs (SUMO-2/3 and SUMO-1) directly interact with MCAF1. SUMOylation of MBD1 facilitates the interaction between MBD1 and MCAF1. Knockdown of SUMO-2/3 or SUMO-1 causes dissociation of MCAF1, trimethyl-H3K9, and HP1 proteins from MBD1-containing heterochromatin foci, demonstrating that SUMOs are required for heterochromatin assembly at MBD1 loci.\",\n      \"method\": \"Co-immunoprecipitation; siRNA knockdown; immunofluorescence\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and KD with localization readout, single lab study\",\n      \"pmids\": [\"16757475\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PML-RARalpha recruits MBD1 to its target promoter through an HDAC3-mediated mechanism. Knockdown of HDAC3 alleviates PML-RAR-induced promoter silencing. Dominant-negative MBD1 mutants in hematopoietic precursors compromise PML-RARalpha's ability to block differentiation, demonstrating that an HDAC3-MBD1 complex is required for PML-RARalpha-mediated transcriptional repression and transformation.\",\n      \"method\": \"ChIP; siRNA knockdown; retroviral expression of dominant-negative MBD1; differentiation assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (ChIP, KD, dominant-negative genetics) with functional cellular readout\",\n      \"pmids\": [\"16432238\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"MBD1 interacts with PcG proteins Ring1b and hPc2 (components of Polycomb repressive complex 1) via its CXXC domains (Ring1b) and the chromodomain of hPc2. Both MBD1 and hPc2 are present at silenced HOXA gene loci; knockdown of either derepresses HOXA genes. An MBD1 mutant lacking CXXC domains loses co-localization with PcG proteins in heterochromatin foci.\",\n      \"method\": \"Co-immunoprecipitation; ChIP; siRNA knockdown; immunofluorescence with domain mutants; 5-azadeoxycytidine treatment\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods including reciprocal Co-IP, ChIP, KD, and domain-mutant localization\",\n      \"pmids\": [\"17428788\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Mbd1 binds to the Fgf-2 promoter in adult neural stem/progenitor cells (NSPCs) and represses its expression via a DNA methylation-dependent mechanism. In Mbd1-deficient NSPCs, the Fgf-2 promoter is hypomethylated and Fgf-2 is upregulated, leading to impaired neuronal differentiation. Acute knockdown of Mbd1 or overexpression of Fgf-2 both inhibit neuronal differentiation.\",\n      \"method\": \"ChIP; bisulfite sequencing; DNA methylation inhibitor treatment; siRNA knockdown; overexpression in adult NSPCs\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP, bisulfite sequencing, and functional KD/OE with differentiation readout, multiple orthogonal methods\",\n      \"pmids\": [\"18689796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"MBD1 directly represses miR-184 expression in adult neural stem/progenitor cells. MBD1 deficiency leads to elevated miR-184, which promotes proliferation and inhibits differentiation. miR-184 targets the 3'-UTR of Numblike (Numbl) mRNA to suppress its translation. Expression of exogenous Numbl rescues the aNSC defects from miR-184 overexpression or MBD1 deficiency, establishing a MBD1→miR-184→Numbl regulatory axis.\",\n      \"method\": \"ChIP; luciferase 3'-UTR reporter assay; miRNA overexpression/inhibition; rescue experiments in aNSCs\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP, reporter assays, gain/loss-of-function, and rescue experiments with multiple orthogonal methods\",\n      \"pmids\": [\"20452318\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The MBD domain of MBD1 binds methylated DNA with sequence-context preference and is necessary and sufficient for recruitment of MBD1 to specific genomic loci in human cells. CXXC3 DNA binding is largely dispensable for in vivo targeting to methylated target genes.\",\n      \"method\": \"ChIP; in vitro DNA binding assays with purified domains; MBD domain point mutants\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP combined with in vitro binding and domain mutants, single lab with multiple methods\",\n      \"pmids\": [\"20378711\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"MBD1 and Sp1-binding MCAF1 form a ternary complex; MCAF1 interacts with MBD1 via its TRD and with Sp1 separately. The MBD1-MCAF complex blocks Sp1-mediated transcription at methylated promoters.\",\n      \"method\": \"Co-immunoprecipitation; in vitro binding; reporter gene assays; MCAF1 knockdown rescue\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and reporter assays, confirmatory of earlier work (PMID:12665582), single lab\",\n      \"pmids\": [\"23349673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"MBD1 forms a complex with Twist and SIRT1 on the CDH1 (E-cadherin) promoter, resulting in reduced E-cadherin transcription and promotion of epithelial-mesenchymal transition in pancreatic cancer cells.\",\n      \"method\": \"Co-immunoprecipitation; ChIP; reporter assays; gain/loss-of-function\",\n      \"journal\": \"Current molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP and ChIP with functional readout, single lab study in cancer cells\",\n      \"pmids\": [\"23331011\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"MBD1 is recruited to DNA damage sites and binds MDC1 (mediator of DNA damage checkpoint protein 1). MBD1 knockdown impairs DNA damage checkpoint activation and reduces DNA repair capacity, sensitizing cells to radiation and cisplatin.\",\n      \"method\": \"Co-immunoprecipitation; siRNA knockdown; DNA damage assays (gamma-H2AX); clonogenic survival assay\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP identifying MDC1 as binding partner combined with KD and functional DNA damage readouts, single lab\",\n      \"pmids\": [\"23588667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The transcriptional regulator Aire interacts with ATF7ip (MCAF1) and MBD1. Mbd1-knockout mice develop autoimmunity with a defect in Aire-dependent thymic expression of tissue-specific antigens, demonstrating that the ATF7ip-MBD1 complex is required for Aire's targeting of TSA loci.\",\n      \"method\": \"Co-immunoprecipitation; Mbd1 knockout mouse phenotyping; transcriptome analysis of thymic epithelial cells\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP combined with in vivo KO phenotype and mechanistic pathway placement\",\n      \"pmids\": [\"24464130\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ATF7IP-MBD1-SETDB1 pathway contributes to X chromosome inactivation maintenance. siRNA-mediated knockdown of Mbd1 or Setdb1, but not unrelated H3K9 methyltransferases, induces activation of silenced Xi-linked reporter genes in mouse embryonic fibroblasts, demonstrating functional specificity within the ATF7IP-MBD1-SETDB1 axis.\",\n      \"method\": \"siRNA knockdown; Xi-linked reporter gene reactivation assay; combined inhibition of multiple Xi maintenance pathways\",\n      \"journal\": \"Epigenetics & chromatin\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — specific KD with reporter readout comparing multiple H3K9 methyltransferases, functional specificity demonstrated\",\n      \"pmids\": [\"25028596\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The C-terminal transcriptional repressor domain (TRD) of MBD1 (residues A529–P592) is intrinsically disordered. Despite lacking tertiary structure, it binds selectively to different partners: MPG and MCAF1 bind both N- and C-terminal residues of the TRD, whereas HDAC3 preferentially binds only the C-terminal region.\",\n      \"method\": \"NMR spectroscopy; protein-protein binding assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structural characterization with binding mapping, single lab but Tier 1 method\",\n      \"pmids\": [\"24810720\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"MBD1 epigenetically silences KEAP1 in pancreatic cancer cells, and c-Myc is an MBD1 interaction partner in this silencing. MBD1 knockdown decreases antioxidant response and ARE-target gene expression through upregulation of KEAP1.\",\n      \"method\": \"Co-immunoprecipitation; ChIP; dual-luciferase reporter assay; siRNA knockdown\",\n      \"journal\": \"Current molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ChIP, and reporter assays in single lab study\",\n      \"pmids\": [\"26980696\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Mbd1 interacts with and enhances Tet1-mediated 5mC oxidation to 5hmC specifically at heterochromatic DNA in mammalian cells, dependent on the CXXC3 domain of Mbd1. The MBD-only isoform (lacking CXXC3) blocks Tet1-mediated 5mC oxidation, showing opposite effects of the two isoforms. Tet1 catalytic activity ultimately leads to displacement of Mbd1 from methylated DNA.\",\n      \"method\": \"Live-cell fluorescence imaging; flow cytometry for 5hmC; ChIP; overexpression of domain deletion mutants\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (imaging, 5hmC quantification, ChIP) with domain-deletion analysis in single focused study\",\n      \"pmids\": [\"28449087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MBD1 represses Oprm1 (mu-opioid receptor) and Kcna2 gene expression in DRG neurons by recruiting DNA methyltransferase DNMT3a to their promoters. MBD1-deficient mice show reduced responses to acute noxious stimuli and blunted neuropathic pain; DRG-specific MBD1 overexpression restores these phenotypes.\",\n      \"method\": \"ChIP; MBD1 knockout mouse; DRG-specific overexpression via viral vector; behavioral pain assays\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ChIP establishing DNMT3a recruitment, combined with KO and rescue/OE with specific behavioral readout\",\n      \"pmids\": [\"30266739\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MBD1 directly inhibits TET1-catalyzed 5mC oxidation kinetics via its MBD domain (which competes for mCpG binding), while the CXXC3 domain of MBD1 promotes TET1 oxidation kinetics by binding the unmethylated CpG product. The transcriptional repressor domain of MBD1 does not affect TET1 regulation, demonstrating distinct domain-specific contributions.\",\n      \"method\": \"Optochemical control of TET1 with photocaged serine; in vivo 5mC oxidation kinetics; MBD1 domain mutants\",\n      \"journal\": \"ACS chemical biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — innovative optochemical kinetic approach with domain mutant analysis, single lab but novel and rigorous method\",\n      \"pmids\": [\"35709470\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MBD1 directly represses miR-5701 expression together with HDAC3 by forming a complex that binds the miR-5701 promoter, which in turn regulates FGFR2 in gastric cancer cells.\",\n      \"method\": \"ChIP; co-immunoprecipitation; siRNA knockdown; luciferase reporter assay\",\n      \"journal\": \"Aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and Co-IP with reporter assay, single lab study\",\n      \"pmids\": [\"35876658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MBD1 is essential for replication fork stability by recruiting PARP1 to stalled replication forks. Loss of MBD1 causes dissociation of PARP1 from forks, increased transcription-replication conflicts (T-R conflicts), elevated R-loops, accelerated fork progression, and DNA2-dependent degradation of stalled forks.\",\n      \"method\": \"Proximity ligation assay combined with EdU (iPOND); R-loop detection; DNA fiber assay; siRNA depletion; PARP1 co-immunoprecipitation\",\n      \"journal\": \"Cancer gene therapy\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (PLA-EdU, fiber assay, R-loop, Co-IP) in single focused study establishing PARP1 as binding partner at forks\",\n      \"pmids\": [\"37949945\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The MBD of human MBD1 binds preferentially to tandem (consecutive) symmetrically methylated CpG sites and DNA forks, with defined binding and dissociation rate constants measured at single-molecule level. This provides a mechanistic model for epigenetic boundary maintenance.\",\n      \"method\": \"Single-molecule kinetics (SiMKEPS) measuring rate constants on DNA substrates with varying CpG patterns and structural motifs\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — rigorous single-molecule in vitro assay but preprint, single lab, not yet peer-reviewed\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"MBD1 is recruited to the Oprm1 promoter following peripheral nerve injury and recruits SUV39H1 to drive H3K9me3-mediated transcriptional silencing of Oprm1 in DRG neurons. Genetic ablation of MBD1 reversed injury-induced MOR downregulation, attenuated H3K9me3 enrichment at the Oprm1 promoter, and alleviated neuropathic pain despite persistent SUV39H1 upregulation.\",\n      \"method\": \"ChIP; MBD1 genetic knockout mouse; behavioral pain assays; western blot\",\n      \"journal\": \"Molecular pain\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with KO genetic model and behavioral functional readout, extends PMID:30266739\",\n      \"pmids\": [\"41090695\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"An MDS-associated long isoform of MBD1 (MBD1-L) arising from aberrant splicing switches MBD1's binding behavior from methylated to unmethylated CpGs, redirecting its heterochromatin-promoting activity and causing broad downregulation of CpG-rich promoters. MBD1-L overexpression in healthy HSPCs recapitulates MDS erythroid differentiation defects. Secondary epigenetic effects are mediated via downstream target BCOR.\",\n      \"method\": \"Isoform overexpression in human HSPCs; ChIP/ATAC-seq; antisense oligonucleotide depletion; differentiation assays\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple genomic and functional methods but preprint, single lab, not yet peer-reviewed\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"MBD1 is a methyl-CpG-binding domain protein that reads DNA methylation via its MBD domain and represses transcription through a C-terminal TRD by assembling context-specific complexes — including CAF-1/MBD1/SETDB1 (during replication-coupled chromatin assembly for H3K9me3 inheritance), MBD1·MCAF1·SETDB1 (for constitutive heterochromatin), MBD1·Suv39h1·HP1 (via the MBD), and HDAC3-MBD1 (recruited by PML-RARα) — while its CXXC3 domain additionally binds unmethylated CpG to enable methylation-independent repression; MBD1 SUMOylation by PIAS1/3 antagonizes SETDB1 recruitment and thus modulates silencing, its CXXC3 domain also promotes TET1-mediated 5mC oxidation at heterochromatin, and MBD1 maintains replication fork stability by recruiting PARP1 and limiting transcription-replication conflicts.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MBD1 is a methyl-CpG-binding transcriptional repressor that translates DNA methylation status into heritable chromatin silencing by reading methylated DNA through its MBD domain and assembling context-specific repressive complexes via a C-terminal transcriptional repression domain (TRD) [#0, #3, #17]. The MBD folds into an alpha/beta sandwich that recognizes methyl groups and CG sequence through a conserved hydrophobic patch, and is necessary and sufficient for targeting MBD1 to methylated loci; it preferentially engages tandem symmetrically methylated CpG sites [#0, #1, #17]. Alternative splicing generates CXXC3-containing isoforms that additionally bind unmethylated CpG, enabling methylation-independent repression and heterochromatin localization [#2, #8]. Silencing is enacted by recruiting histone-modifying machinery: MBD1 couples H3K9 methylation to histone deacetylation through Suv39h1/HP1 and through HDAC3, and assembles an MBD1·MCAF1(ATF7IP)·SETDB1 complex required for heterochromatin formation, including an S-phase CAF-1/MBD1/SETDB1 complex that propagates H3K9 methylation during replication-coupled chromatin assembly [#3, #4, #6, #7, #9, #23]. SUMOylation of MBD1 by PIAS1/3 antagonizes SETDB1 recruitment, providing a switch that modulates the silencing output [#11]. Through these activities MBD1 maintains X-inactivation and Aire-dependent thymic tolerance, and directs neural and neuronal gene programs by repressing Fgf-2, miR-184, and Oprm1 via DNA-methylation-dependent and DNMT3a/SUV39H1-coupled mechanisms [#15, #16, #21, #22, #26, #31]. Beyond transcription, MBD1 acts at the replication fork, recruiting PARP1 to stabilize stalled forks and limit transcription-replication conflicts, and its CXXC3 domain tunes TET1-mediated 5mC oxidation at heterochromatin [#25, #27, #29].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing how MBD1 physically reads its substrate, the free and methylated-DNA-bound MBD structures defined the alpha/beta-sandwich fold and the conserved residues that recognize methyl-CpG, providing the structural basis for methylation reading.\",\n      \"evidence\": \"NMR solution structures of free and methylated-DNA-bound MBD with site-directed mutagenesis\",\n      \"pmids\": [\"10581239\", \"11371345\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structures of full-length MBD1 or its complexes not determined\", \"Does not address how MBD selectivity is tuned across genomic contexts\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Discovery that alternative splicing produces CXXC3-containing isoforms binding unmethylated DNA showed MBD1 represses both methylated and unmethylated promoters through distinct domains, revealing two parallel targeting modes.\",\n      \"evidence\": \"GFP-isoform transfection in methylation-deficient and mammalian cells, reporter assays, EMSA\",\n      \"pmids\": [\"10454587\", \"10866667\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative in vivo contributions of MBD vs CXXC3 targeting not resolved here\", \"Tissue-specific isoform usage unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Mapping the C-terminal TRD and its HDAC-inhibitor sensitivity established MBD1 as an active repressor dependent on histone deacetylation, distinct from the MeCP1 complex.\",\n      \"evidence\": \"Reporter assays, trichostatin A treatment, immunofluorescence, co-immunoprecipitation\",\n      \"pmids\": [\"10648624\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct deacetylase partner not identified at this stage\", \"Mechanism of repression at a distance unexplained\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification of Suv39h1/HP1, CAF-1 p150, and the MCAF mediator as MBD1 partners explained how MBD1 couples DNA methylation reading to H3K9 methylation, heterochromatin, and Sp1-blocking repression.\",\n      \"evidence\": \"GST pulldown, reciprocal Co-IP, yeast two-hybrid, immunofluorescence colocalization, dominant-negative overexpression, reporter assays\",\n      \"pmids\": [\"12711603\", \"12697822\", \"12665582\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How these complexes are temporally coordinated not yet defined\", \"Stoichiometry and exclusivity of complexes unknown\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"The S-phase-specific CAF-1/MBD1/SETDB1 complex showed MBD1 propagates H3K9 methylation during replication-coupled chromatin assembly, linking methylation maintenance to chromatin inheritance.\",\n      \"evidence\": \"Co-IP, ChIP, siRNA knockdown, S-phase cell fractionation\",\n      \"pmids\": [\"15327775\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct demonstration of mark inheritance across generations not shown\", \"Genome-wide scope of affected loci limited\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Demonstrating that CXXC3 binds nonmethylated CpG in vivo clarified the basis for methylation-independent heterochromatin localization and repression of unmethylated targets.\",\n      \"evidence\": \"Domain-mutant transfection, DNA binding assays, fluorescence microscopy in methylation-deficient cells\",\n      \"pmids\": [\"15060159\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Endogenous nonmethylated targets not catalogued\", \"Interplay with MBD-based targeting unresolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defining MCAF1/MCAF2 as bridging factors linking MBD1, SETDB1, and Sp1 established the MBD1·MCAF1·SETDB1 complex as the core machinery for heterochromatic domain formation.\",\n      \"evidence\": \"Co-IP, in vitro binding, siRNA knockdown, immunofluorescence with domain mutants, reporter assays\",\n      \"pmids\": [\"15691849\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Distinct roles of MCAF1 vs MCAF2 not separated\", \"Recruitment hierarchy at native loci unclear\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Discovery of SUMOylation by PIAS1/3 and SUMO-dependent MCAF1 binding revealed a post-translational switch controlling whether MBD1 assembles the repressive SETDB1 complex.\",\n      \"evidence\": \"In vivo sumoylation assays, site-directed mutagenesis of acceptor lysines, Co-IP, siRNA knockdown, reporter assays, immunofluorescence\",\n      \"pmids\": [\"17066076\", \"16757475\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals controlling MBD1 SUMOylation dynamics unknown\", \"How SUMO simultaneously blocks SETDB1 yet aids MCAF1 binding is mechanistically unreconciled\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Placing an HDAC3-MBD1 complex downstream of PML-RARalpha connected MBD1 to oncogenic transcriptional silencing and a block to hematopoietic differentiation.\",\n      \"evidence\": \"ChIP, siRNA knockdown, dominant-negative MBD1 expression, differentiation assays\",\n      \"pmids\": [\"16432238\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct MBD1-HDAC3 contact details limited\", \"Generality beyond PML-RARalpha targets not tested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Linking MBD1 to PRC1 components Ring1b and hPc2 via its CXXC domains extended MBD1 silencing to Polycomb-controlled HOXA loci.\",\n      \"evidence\": \"Co-IP, ChIP, siRNA knockdown, domain-mutant immunofluorescence, 5-azadeoxycytidine treatment\",\n      \"pmids\": [\"17428788\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect nature of PRC1 association not fully resolved\", \"Genome-wide overlap with Polycomb domains undefined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identifying Mbd1 repression of Fgf-2 in adult neural stem cells assigned MBD1 a physiological role in neuronal differentiation via methylation-dependent silencing.\",\n      \"evidence\": \"ChIP, bisulfite sequencing, methylation inhibitor, siRNA knockdown, overexpression in NSPCs\",\n      \"pmids\": [\"18689796\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Mbd1 loss leads to promoter hypomethylation not explained\", \"Full neural target set not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"The MBD1→miR-184→Numbl axis and refined ChIP/in vitro mapping established that the MBD domain is the principal in vivo targeting determinant and that MBD1 controls neural stem cell fate through a miRNA circuit.\",\n      \"evidence\": \"ChIP, luciferase 3'-UTR reporters, miRNA gain/loss, rescue experiments, in vitro domain binding, MBD point mutants\",\n      \"pmids\": [\"20452318\", \"20378711\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"When CXXC3 targeting becomes functionally relevant remains unclear\", \"Broader miRNA targets of MBD1 not surveyed\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Showing the TRD is intrinsically disordered yet binds distinct partners (MPG, MCAF1, HDAC3) explained how a single repression module recruits multiple effectors.\",\n      \"evidence\": \"NMR spectroscopy and protein-protein binding mapping\",\n      \"pmids\": [\"24810720\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Conformational states upon binding not resolved\", \"Functional consequence of competitive partner binding untested\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"In vivo knockout studies placed the ATF7IP-MBD1-SETDB1 axis in Aire-dependent thymic tolerance and X-inactivation maintenance, demonstrating MBD1's role in organismal epigenetic silencing programs.\",\n      \"evidence\": \"Co-IP, Mbd1 knockout mouse phenotyping and thymic transcriptomics, Xi-linked reporter reactivation with pathway-specific knockdowns\",\n      \"pmids\": [\"24464130\", \"25028596\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct chromatin targets at Xi and TSA loci incompletely mapped\", \"Whether the same complex operates at both contexts is not directly compared\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Cancer-context studies linked MBD1 to EMT and antioxidant control by forming repressive complexes (Twist/SIRT1 at CDH1; c-Myc at KEAP1) at specific promoters.\",\n      \"evidence\": \"Co-IP, ChIP, reporter assays, gain/loss-of-function in cancer cells\",\n      \"pmids\": [\"23331011\", \"26980696\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab studies without reciprocal validation across systems\", \"Direct vs indirect promoter occupancy not always resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstrating opposite domain-specific effects on TET1 — MBD inhibiting and CXXC3 promoting 5mC oxidation — recast MBD1 as an active modulator of DNA demethylation at heterochromatin rather than a passive reader.\",\n      \"evidence\": \"Live-cell imaging, 5hmC flow cytometry, ChIP, domain-deletion mutants; optochemical TET1 kinetics with domain mutants\",\n      \"pmids\": [\"28449087\", \"35709470\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo balance between the two isoforms genome-wide unknown\", \"Physiological loci where TET1 modulation matters not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Linking MBD1 to DNMT3a recruitment at Oprm1/Kcna2 and later to SUV39H1-driven H3K9me3 silencing established MBD1 as a driver of injury-induced gene silencing underlying neuropathic pain.\",\n      \"evidence\": \"ChIP, MBD1 knockout mice, DRG-specific viral overexpression/rescue, behavioral pain assays, western blot\",\n      \"pmids\": [\"30266739\", \"41090695\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How MBD1 is recruited after nerve injury not fully mechanistic\", \"Relative contributions of DNMT3a vs SUV39H1 arms not dissected\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Finding MBD1 at DNA damage sites bound to MDC1 and required for checkpoint activation extended its function into the DNA damage response.\",\n      \"evidence\": \"Co-IP, siRNA knockdown, gamma-H2AX assays, clonogenic survival\",\n      \"pmids\": [\"23588667\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single Co-IP without reciprocal validation of MDC1 interaction\", \"Whether recruitment depends on chromatin reading is unclear\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identifying MBD1 as a PARP1-recruiting factor that stabilizes stalled replication forks and limits transcription-replication conflicts defined a non-transcriptional genome-maintenance role.\",\n      \"evidence\": \"iPOND/PLA-EdU, R-loop detection, DNA fiber assays, siRNA depletion, PARP1 Co-IP\",\n      \"pmids\": [\"37949945\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How MBD1 selects stalled forks mechanistically unknown\", \"Relationship to its transcriptional silencing functions not integrated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Single-molecule kinetics showed the MBD prefers tandem symmetric methyl-CpG and DNA forks, offering a model for epigenetic boundary maintenance.\",\n      \"evidence\": \"SiMKEPS single-molecule rate-constant measurements (preprint) on varied CpG/structural substrates\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, not yet peer-reviewed\", \"In vitro kinetics not validated against in vivo occupancy\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Characterizing an MDS-associated long isoform that switches MBD1 from methylated to unmethylated CpG binding linked aberrant splicing of MBD1 to a hematopoietic differentiation disease phenotype via BCOR.\",\n      \"evidence\": \"Isoform overexpression in human HSPCs, ChIP/ATAC-seq, antisense depletion, differentiation assays (preprint)\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint, not yet peer-reviewed\", \"Causal role of MBD1-L in patient disease not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How MBD1's distinct functional modes — methylation-dependent silencing, methylation-independent CXXC3 targeting, TET1 modulation, and replication-fork protection — are coordinated within a cell and across the cell cycle remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No integrated model linking transcriptional and replication-fork roles\", \"Genome-wide isoform- and modification-state-resolved occupancy lacking\", \"Structure of full-length MBD1 or its native complexes undetermined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 1, 2, 8, 17, 30]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [2, 3, 6, 7, 9]},\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [25, 27]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [3, 5, 10]},\n      {\"term_id\": \"GO:0000228\", \"supporting_discovery_ids\": [3, 5, 7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [4, 7, 9, 22]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [3, 6, 15, 16, 26]},\n      {\"term_id\": \"R-HSA-69306\", \"supporting_discovery_ids\": [7, 29]},\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [20, 29]}\n    ],\n    \"complexes\": [\n      \"CAF-1/MBD1/SETDB1\",\n      \"MBD1\\u00b7MCAF1(ATF7IP)\\u00b7SETDB1\",\n      \"MBD1\\u00b7Suv39h1\\u00b7HP1\",\n      \"HDAC3-MBD1\"\n    ],\n    \"partners\": [\n      \"SETDB1\",\n      \"MCAF1\",\n      \"SUV39H1\",\n      \"HP1\",\n      \"CAF-1 p150\",\n      \"HDAC3\",\n      \"PARP1\",\n      \"PIAS1\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}